Ovarian germ cell tumor natural history: Difference between revisions
| Line 27: | Line 27: | ||
**It happens at a greater extent in intermediate-sized tumors. | **It happens at a greater extent in intermediate-sized tumors. | ||
*Rupture in < 4% of the affected individuals. | *Rupture in < 4% of the affected individuals. | ||
*Malignant transformation of the tumor may also happen in approximately 2% of affected individuals. | *This tumor may be bilateral in 8% to 15% of cases. | ||
* | *Malignant transformation of the tumor may also happen in approximately 2% of affected individuals.<ref name="pmid2841767">{{cite journal |vauthors=Singh P, Yordan EL, Wilbanks GD, Miller AW, Wee A |title=Malignancy associated with benign cystic teratomas (dermoid cysts) of the ovary |journal=Singapore Med J |volume=29 |issue=1 |pages=30–4 |date=February 1988 |pmid=2841767 |doi= |url=}}</ref> | ||
**The tumor undergoes malignant transformation to squamous cell carcinma in 80% of them and to adenocarcinoma in the rest of the cases. | |||
===Prognosis=== | ===Prognosis=== | ||
*Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%. | *Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%. | ||
Revision as of 21:19, 25 February 2019
|
Ovarian germ cell tumor Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Ovarian germ cell tumor natural history On the Web |
|
American Roentgen Ray Society Images of Ovarian germ cell tumor natural history |
|
Risk calculators and risk factors for Ovarian germ cell tumor natural history |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
The prognosis of germ cells of the ovary depends on the type of the tumor and its malignant potentials. Possible complications of benign teratomas are a rupture and ovarian torsion also malignant transformation. If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
Natural History, Complications, and Prognosis
Natural History
- The symptoms of ovarian germ cell tumors usually develop in the teenage years with abdominal pain or fullness, and palpable pelvic/abdominal mass.[1]
- The symptoms of (disease name) typically develop ___ years after exposure to ___.
- If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
Complications
Mature teratoma
Common complications of mature teratoma include:[2]
- Ovarian torsion is the most common complication and affects 5% to 10% of the individuals.
- It happens at a greater extent in intermediate-sized tumors.
- Rupture in < 4% of the affected individuals.
- This tumor may be bilateral in 8% to 15% of cases.
- Malignant transformation of the tumor may also happen in approximately 2% of affected individuals.[3]
- The tumor undergoes malignant transformation to squamous cell carcinma in 80% of them and to adenocarcinoma in the rest of the cases.
Prognosis
- Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [--]%.
- Depending on the extent of the [tumor/disease progression] at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor/good/excellent.
- The presence of [characteristic of disease] is associated with a particularly [good/poor] prognosis among patients with [disease/malignancy].
- [Subtype of disease/malignancy] is associated with the most favorable prognosis.
- The prognosis varies with the [characteristic] of tumor; [subtype of disease/malignancy] have the most favorable prognosis.
References
- ↑ Low, Jeffrey J.H.; Ilancheran, Arunachalam; Ng, Joseph S. (2012). "Malignant ovarian germ-cell tumours". Best Practice & Research Clinical Obstetrics & Gynaecology. 26 (3): 347–355. doi:10.1016/j.bpobgyn.2012.01.002. ISSN 1521-6934.
- ↑ Ayhan, Ali; Bukulmez, Orhan; Genc, Cuneyt; Karamursel, Burcu S.; Ayhan, Ayse (2000). "Mature cystic teratomas of the ovary: case series from one institution over 34 years". European Journal of Obstetrics & Gynecology and Reproductive Biology. 88 (2): 153–157. doi:10.1016/S0301-2115(99)00141-4. ISSN 0301-2115.
- ↑ Singh P, Yordan EL, Wilbanks GD, Miller AW, Wee A (February 1988). "Malignancy associated with benign cystic teratomas (dermoid cysts) of the ovary". Singapore Med J. 29 (1): 30–4. PMID 2841767.